Close
The world’s first biotech platform to naturally provide protection against viruses, bacteria and parasites.
With BEEMAR™, cellNUA is introducing the world to its universal platform to fight infectious disease… one that is capable of solving the global immunity crisis.
In collaboration with cellNUA’s international R&D partners the BEEMAR™ platform has been developed as an ideal model to prepare for the next pandemic, PANDEMIC X.
The discovery made by cellNUA is based on the world’s first comparative genomic mapping of the sequenced human and honeybee genome.
‘We believe BEEMAR™ will be the world’s first natural, synthetic-free immunotherapeutic platform to partner with the body’s cells to produce critical reinforcement against pathogenic threats.’
John Kelleher, Chairman cellNUA
Driven by a reverence for all living things and an unwavering commitment to respectfully harnessing Nature’s Intelligence ™, cellNUA is an Ireland-based, biotech company with expertise in Immunology, Virology and Cell Therapy Innovation.
Our international team of scientific researchers have proficiency and insight into nature’s perfectly designed solutions in addressing many of the critical healthcare issues that plague humans and animals.
Driven by a reverence for all living things and an unwavering commitment to respectfully harnessing Nature’s Intelligence™, cellNUA is an Ireland-based, biotech company with expertise in Immunology, Virology and Cell Therapy Innovation.
